Overall, CSF Ng levels appear to be equally high in aMCI and dementia stages of AD, but in FTLD, as the disease processes underlying FTLD progress from MCI to dementia stage, elevation of CSF Ng becomes more prominent and similar to AD dementia. This evidence concerns the gene NRGN and dementia.